NEW YORK (GenomeWeb News) – Metabolomics-based diagnostic firm Matrix-Bio today said it has signed an agreement with Quest Diagnostics covering the use of metabolomic biomarkers to develop a test for breast cancer recurrence.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.
The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.
A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.
Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.